Your session is about to expire
← Back to Search
Home Transfusion Program for Blood Cancer
N/A
Recruiting
Led By Oreofe O Odejide, MD, MPH
Research Sponsored by Dana-Farber Cancer Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
Study Summary
This trial is testing a program that would let people with cancer who need blood transfusions do them at home.
Who is the study for?
This trial is for adults over 18 with advanced blood cancers who've had at least one safe transfusion, are under the care of DFCI, and have a prognosis of six months or less. They must live with an adult caregiver within a specific area served by Care Dimensions Hospice.Check my eligibility
What is being tested?
The study is evaluating the effectiveness of administering blood transfusions at home for patients with blood cancers. It aims to determine if this approach is practical and well-received by both patients and their caregivers.See study design
What are the potential side effects?
While specific side effects aren't listed, typical risks may include discomfort at the infusion site, allergic reactions, fatigue after the transfusion, or rare complications like infection from the procedure.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Completion of Home Transfusions and Patient-Reported Data
Enrollment Rate
Secondary outcome measures
Disenrollment Rate
Satisfaction Rate
Trial Design
1Treatment groups
Experimental Treatment
Group I: Home TransfusionExperimental Treatment1 Intervention
This research study involves completing questionnaires, a brief interview, blood draws, and blood transfusions when needed.
Home Transfusion Program Components
Participants will be in the research study for up to six months
Find a Location
Who is running the clinical trial?
Dana-Farber Cancer InstituteLead Sponsor
1,079 Previous Clinical Trials
340,960 Total Patients Enrolled
2 Trials studying Blood Cancers
90 Patients Enrolled for Blood Cancers
Oreofe O Odejide, MD, MPHPrincipal InvestigatorDana-Farber Cancer Institute
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am under 18 years old.I have worsening symptoms of heart failure.I am under 18 years old.I am 18 years old or older.My caregiver is under 18 years old.I have been diagnosed with a blood cancer.I've had a blood transfusion since my blood cancer diagnosis without major issues.
Research Study Groups:
This trial has the following groups:- Group 1: Home Transfusion
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is there currently an opportunity for individuals to join the research?
"Clinicaltrials.gov data suggests this trial is not currently recruiting, with the initial advertisement being posted on November 1st and last edited October 17th 2022. However, there are still 2,525 other research studies actively looking for volunteers at this time."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger